D

Aclaris Therapeutics, Inc. ACRS

NASDAQ
Recommendation
Dividend Power Score
Day's Range
$3.40$3.55
Latest Close
Volume
--
Avg Vol (90D)
Market Cap
Dividend & Yield
--
P/E (TTM)
--
EPS (TTM)
My Lists My Alerts

09/30/2026 06/30/2026 03/31/2026 12/31/2025 09/30/2025
Revenue 1.48M 1.63M 2.00M 1.30M 3.30M
Total Other Revenue -- -- -- -- --
Total Revenue 1.48M 1.63M 2.00M 1.30M 3.30M
Cost of Revenue 17.39M 19.52M 17.45M 18.05M 15.48M
Gross Profit -15.91M -17.89M -15.45M -16.76M -12.18M
SG&A Expenses 6.04M 6.05M 6.74M 5.58M 4.87M
Depreciation & Amortization -- -- -- -- --
Other Operating Expenses -- -- -- -- --
Total Operating Expenses 23.43M 25.57M 24.19M 23.63M 20.35M
Operating Income -21.94M -23.94M -22.19M -22.33M -17.05M
Income Before Tax -18.51M -21.51M -19.82M -19.80M -14.61M
Income Tax Expenses -- -- -- -- --
Earnings from Continuing Operations -18.51M -21.51M -19.82M -19.80M -14.61M
Earnings from Discontinued Operations -- -- -- -- --
Extraordinary Item & Accounting Change -- -- -- -- --
Minority Interest in Earnings -- -- -- -- --
Net Income -18.51M -21.51M -19.82M -19.80M -14.61M
EBIT -21.94M -23.94M -22.19M -22.33M -17.05M
EBITDA -- -23.94M -22.19M -22.32M -17.04M
EPS Basic -0.12 -0.15 -0.15 -0.16 -0.12
Normalized Basic EPS -0.08 -0.09 -0.10 -0.10 -0.07
EPS Diluted -0.12 -0.15 -0.15 -0.16 -0.12
Normalized Diluted EPS -0.08 -0.09 -0.10 -0.10 -0.07
Average Basic Shares Outstanding 149.45M 142.74M 128.81M 122.66M 122.62M
Average Diluted Shares Outstanding 149.45M 142.74M 128.81M 122.66M 122.62M
Dividend Per Share -- -- -- -- --
Payout Ratio -- -- -- -- --